OR51R1P

Across TCGA pan-cancer cohorts, OR51R1P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated OR51R1P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR51R1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR51R1P expression acts as an unfavorable survival marker, although some lineages such as SKCM and PAAD show a favorable association.

MESO, HNSC, and LGG are the cancer types where OR51R1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	III,IV	0.086	0.584	<.001	144	view →
HNSC	OS	Tertile	III,IV	0.425	0.643	.001	66	view →
LGG	DFS	Tertile	All	0.515	0.754	<.001	39	view →
KICH	DFS	Tertile	All	0.102	0.848	.004	39	view →
CHOL	OS	Tertile	II,III,IV	0.186	0.743	.007	27	view →
SKCM	DFS	Tertile	All	0.427	0.194	.006	24	view →
ESCA	DFS	Tertile	All	0.374	0.833	.002	21	view →
UVM	OS	Tertile	All	0.248	0.769	.007	18	view →
TGCT	OS	Tertile	All	0.542	0.969	<.001	18	view →
THYM	OS	Tertile	All	0.712	0.971	.016	15	view →
PAAD	DFS	Tertile	All	0.851	0.265	.024	15	view →
LUSC	DFS	Tertile	All	0.508	0.655	.035	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

OR51R1P–MESO (OS)

Open the MESO breakdown →